Reduced RBM5 protein expression in the NSCLC tissues was also significantly positively correlated with lymph node metastasis of NSCLC patients (50 vs. 34 or 83 % vs. 56.7 %; P = 0.008). Here, RBM5 is linked to metastatic malignant neoplasm in the lymph nodes.